Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation
Citation:
Simon A, Amaro MI, Healy AM, Cabral LM, de Sousa VP, Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation, International Journal of Pharmaceutics, 512, 1, 2016, 234 - 241Download Item:
Abstract:
In the present study, in vitro permeation experiments in a Franz diffusion cell were performed using different synthetic polymeric membranes and pig ear skin to evaluate a rivastigmine (RV) transdermal drug delivery system. In vitro-in vivo correlations (IVIVC) were examined to determine the best model membrane. In vitro permeation studies across different synthetic membranes and skin were performed for the Exelon® Patch (which contains RV), and the results were compared. Deconvolution of bioavailability data using the Wagner–Nelson method enabled the fraction of RV absorbed to be determined and a point-to-point IVIVC to be established. The synthetic membrane, Strat-M™, showed a RV permeation profile similar to that obtained with pig ear skin (R2 = 0.920). Studies with Strat-M™ resulted in a good and linear IVIVC (R2 = 0.991) when compared with other synthetic membranes that showed R2 values less than 0.90. The R2 for pig ear skin was 0.982. Strat-M™ membrane was the only synthetic membrane that adequately simulated skin barrier performance and therefore it can be considered to be a suitable alternative to human or animal skin in evaluating transdermal drug transport, potentially reducing the number of studies requiring human or animal samples.
Sponsor
Grant Number
Science Foundation Ireland (SFI)
12/RC/2275
Author's Homepage:
http://people.tcd.ie/healyamDescription:
PUBLISHEDExport Date: 13 December 2016
Author: HEALY, ANNE
Type of material:
Journal ArticleSeries/Report no:
International Journal of Pharmaceutics512
1
Availability:
Full text availableDOI:
http://dx.doi.org/10.1016/j.ijpharm.2016.08.052Metadata
Show full item recordLicences: